Global PCR Testing Products & Services
This report forecasts the world market for life science and clinical applications of polymerase chain reaction (PCR) and other nucleic acid amplification test (NAAT) technology to 2021 in US dollars. Market segments include clinical NAAT, life science NAAT, and other NAAT. The clinical NAAT market is segmented by disease indication (infectious disease, oncology, genetic testing, transplantation, other diagnostics, and blood screening) and by region (US, Europe, Japan, China, Latin America, and the rest of the world). The life science NAAT market is segmented by product (reagents/consumables, instruments, and software and services).
To illustrate historical trends, the world market and the various segments are provided for 2016. A Global Overview and Forecasts section provides pertinent background on nucleic acid amplification testing, market drivers and challenges, and the clinical and life science NAAT markets.
Further analysis includes an Industry Structure section, which surveys the supply base and profiles the leading firms competing in the global market. An introductory Highlights section summarizes key findings from this 28-page report, and a Resources section lists contributing sources as well as resources available for further research.
Back to Top